Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Go back to Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency| (NASDAQ: LUMO) | Delayed: 2.80 +0.12 (4.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.68 | 52 Week High | $ | |||
| Open | $2.73 | 52 Week Low | $ | |||
| Day High | $2.85 | P/E | N/A | |||
| Day Low | $2.73 | EPS | $ | |||
| Volume | 7,228 | |||||
